Axonics® to Report 2019 Third Quarter and Nine-Month Financial Results and Host a Conference Call on November 14 by Carolyn Helms | Nov 7, 2019 | Portfolio News
Aimmune Therapeutics Announces Third Quarter 2019 Financial Results and Provides Operational Highlights by Carolyn Helms | Nov 6, 2019 | Portfolio News
Axonics® Announces First Commercial U.S. Patient Implanted with its Sacral Neuromodulation System by Carolyn Helms | Nov 1, 2019 | Portfolio News
Akebia Therapeutics to Report Third Quarter 2019 Financial Results and Discuss Recent Business Highlights by Carolyn Helms | Oct 28, 2019 | Portfolio News
Talaris Therapeutics Announces Initiation of Phase 3 Clinical Trial of FCR001 in Living Donor Kidney Transplant Recipients by Carolyn Helms | Oct 23, 2019 | Portfolio News
